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Abstract
The North West Adelaide Health Study is a population-based biomedical cohort study investigating the
prevalence of a number of chronic conditions and health-related risk factors along a continuum. This methodology
may assist with evidence-based decisions for health policy makers and planners, and inform health professionals
who are involved in chronic disease prevention and management, by providing a better description of people at
risk of developing or already diagnosed with selected chronic conditions for more accurate targeting groups for
health gain and improved health outcomes. Longitudinal data will provide information on progression of chronic
conditions and allow description of those who move forward and back along the continuum over time.
Detailed methods are provided regarding the random recruitment and examination of a representative sample of
participants (n = 4060), including the rationale for various processes and valuable lessons learnt. Self-reported and
biomedical data were obtained on risk factors (smoking, alcohol consumption, physical activity, family history,
body mass index, blood pressure, cholesterol) and chronic conditions (asthma, chronic obstructive pulmonary
disease, diabetes) to classify participants according to their status along a continuum. Segmenting this population
sample along a continuum showed that 71.5% had at least one risk factor for developing asthma, chronic
obstructive pulmonary disease or diabetes. Almost one-fifth (18.8%) had been previously diagnosed with at least
one of these chronic conditions, and an additional 3.9% had at least one of these conditions but had not been
diagnosed.
This paper provides a novel opportunity to examine how a cohort study was born. It presents detailed
methodology behind the selection, recruitment and examination of a cohort and how participants with selected
chronic conditions can be segmented along a continuum that may assist with health promotion and health services
planning.
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Introduction
In westernised countries, chronic diseases now account
for approximately 60% of global deaths and almost half
of the global burden of disease [1]. In Australia, chronic
conditions such as diabetes, asthma, and chronic obstruc-
tive pulmonary disease (COPD) contribute significantly
to the burden of disease, and are listed among the top ten
leading causes of death [2]. Diabetes and asthma are rec-
ognized as Australian health priorities because of the sig-
nificant impact they have on those people with the
condition, their families, health professionals and the
health system [3]. Large epidemiological cohort studies of
randomly selected participants can assist in the fight
against the global chronic disease epidemic by providing
intelligence on the development of multiple outcomes
and changing chronic disease risks over time, as well as
the modification of lifestyle and risk factors [4]. The North
West Adelaide Health Study (NWAHS) is a longitudinal
cohort of over 4000 randomly selected adults aged 18
years and over, who live in the northern and western
regions of Adelaide (total Adelaide population approxi-
mately 1 million), the capital of South Australia (total
South Australian population approximately 1.3 million)
[5,6].
A major challenge for epidemiologists and public health
professionals is to paint the chronic disease picture in new
and innovative ways that may galvanise action by
researchers, governments and communities. Identifying
and describing specific population groups at risk (the
term "at risk" is used in this paper in the policy and collo-
quial sense, meaning "high risk") may assist in maximiz-
ing the effectiveness of strategies for the prevention, early
detection, and management of chronic conditions. The
chronic conditions focused on in Stage 1 of the NWAHS
were asthma, COPD and diabetes. Whilst recognising the
significant impact of cancer and infectious diseases on
society, it was considered that these conditions are being
well-researched and managed by specialised teams of
health professionals within the State.
The NWAHS is a collaboration between the South Austral-
ian Department of Health, the Central Northern Adelaide
Health Service (including The Queen Elizabeth Hospital
& Health Service (TQEH) and the Lyell McEwin Health
Service (LMHS) campuses), The University of Adelaide,
the University of South Australia and the Institute of Med-
ical & Veterinary Science (IMVS). The research team repre-
sents a range of disciplines including academic and
clinical medicine, public health, epidemiology, social sci-
ence and nursing, using quantitative and qualitative
methodologies. Collaborative longitudinal studies such
as this one enhance the nature of epidemiological
research [7] because of the specialist knowledge contrib-
uted and the co-operation between researchers, health
professionals, policy makers and the community, which
contributes to scientific endeavour and productivity. The
importance of these collaborations have been recognised
and expanded, and the next stage of the study (in progress
during 2004 and 2005) has led to alliances being sought
with a leading demographer to map the distribution of
chronic diseases, risk factors and biographic information,
as well as medical practitioners in the fields of arthritis,
obesity, mental health and cardiovascular disease – add-
ing to established relationships with experts in asthma,
COPD and diabetes. In recognition that health and dis-
ease are also influenced at both the individual and com-
munity level, and with a growing demand for information
from a health inequalities perspective, social sciences such
as sociology and anthropology are increasingly being used
to view health in general, and prevention of disease in par-
ticular. The multidisciplinary nature of the study has
incorporated this approach through qualitative investiga-
tions of participants' experience of being involved in the
study, experiences of people living with chronic condi-
tions [8], and information needs of people with diabetes
[9].
The focus of this paper is two-pronged: a detailed descrip-
tion of Stage 1 of the study methodology (including
design, sample techniques and clinic protocols), as well as
a segmentation of the study's representative population
sample according to stage of selected chronic diseases
along a continuum. The more effectively those with spe-
cific conditions are described, the more precisely they can
be targeted by designing policy and interventions that
consider a range of appropriate characteristics to reduce
the prevalence and risk of chronic conditions in the pop-
ulation.
Analysis
Background and purpose of the study
The NWAHS was formulated in 1997 by Professor Richard
Ruffin and Associate Professor David Wilson, in response
to the lack of longitudinal biomedical data on chronic
conditions in South Australia. Trend analyses of data from
South Australian Health Omnibus Surveys (HOS) [10] in
the 1990's were revealing increases in the prevalence of
diabetes [11] and asthma [12]. These face-to-face inter-
view surveys, whilst providing valuable representative
population data from large clustered samples on the self-
reported prevalence of diagnosed chronic conditions such
as asthma and diabetes, did not provide cohort data on a
single randomly selected population nor biomedically
measured data that could be used to segment the popula-
tion along the chronic disease continuum.
The main aim of Stage 1 of the study cohort was to estab-
lish urgently needed baseline self-reported and biomedi-
cally measured information on diabetes, asthma andEpidemiologic Perspectives & Innovations 2006, 3:4 http://www.epi-perspectives.com/content/3/1/4
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COPD and health-related risk factors in terms of a contin-
uum, consisting of three main categories: those who were
(1) at risk (see Introduction, paragraph 2) of these dis-
eases; (2) previously undiagnosed with these diseases;
and (3) previously diagnosed with those diseases (Figure
1). In addition to gaining insight into the management of
chronic conditions and co-morbidities among those who
have been diagnosed, identifying the additional catego-
ries of "at risk" (see Introduction, paragraph 2) and "pre-
viously undiagnosed" along the continuum provides a
clearer statement of disease burden and epidemiological
description of target groups, and presents opportunities
for effective intervention, health service usage and health
policy. Secondary aims from the longitudinal nature of
the study include: (1) determination of incidence rates for
a number of chronic diseases; (2) examination of changes
in patterns of severity, management costs and utilisation
of resources; (3) investigation of the impact of existing
and future guidelines, including possible barriers to their
implementation; and (4) provision of a high quality data-
base for other health researchers to access for value-added
chronic disease and/or risk factor related research. The
NWAHS baseline data can also be used to compare
reported and measured variables, particularly height and
weight, as well as corroborate survey data regarding the
prevalence of a number of health conditions and
unhealthy behaviours among adults living the north west-
ern regions of Adelaide.
Timeline
There were two phases involved in Stage 1 of the study,
which involved the recruitment and baseline examination
of the 4060 study participants: Phase 1A from December
1999 to December 2000 (n = 2523), and Phase 1B from
August 2002 to July 2003 (n = 1537). Both phases used
the same methodology for all aspects of the study, with
the exception of an additional small number of questions
in the telephone interview, the self-reported question-
naire and during the clinic examination (see Table 1).
Selection of the sample population
Prior to the study commencing, approval for the research
was obtained from the North West Adelaide Health Serv-
ice Ethics of Human Research Committee. All households
in the northern and western areas of Adelaide with a tele-
phone connected and a telephone number listed in the
Electronic White Pages (EWP) were eligible for selection
in the study. The sample was stratified into two health
regions: northern Adelaide and western Adelaide. The
northern and western regions of Adelaide number
approximately half of the city's population and one quar-
ter of South Australia's population. These regions reflect
the demographic profile of the State's population.
Recruitment
Participants were recruited using the telephone to conduct
the interviews and the Electronic White Pages (EWP) as
the sampling frame, which could be seen as a limitation
of the study in that it may produce biased estimates
because it excludes people who do not have a telephone
connected or are not listed in the White Pages. However
the alternative, random digit dialling (RDD), requires a
significant amount of initial administrative work, can
have lower response rates than EWP (often accessing busi-
ness or other irrelevant telephone numbers) and is con-
siderably more costly due to the number of calls required
[13]. It has been shown, however, that there are no differ-
ences between random digit dialling and EWP in terms of
the prevalence of chronic conditions [14]. In addition,
people without their telephone number listed in the
White Pages have been shown to be similar to those with
a listed number in terms of reported health and risk fac-
tors [13]. Telephone surveys using CATI (Computer
Assisted Telephone Interview) technology also have
administrative and data collection advantages over other
methods including automatic checks to reduce data entry
errors, and the ability to conduct complicated question-
naire sequences based on previous responses [15].
Within each household, the person who had their birth-
day last and was aged 18 years and over, was selected for
interview and invited to attend the clinic for a biomedical
examination. This method of randomly selecting within
the household avoids bias towards unemployed and
retired people or homemakers (often women) as those
most likely to be home at the time that the interviews are
conducted [16]. The response rate to the study is shown in
Figure 2. To minimize potential bias due to differing prob-
abilities of selection in the sample, the data were weighted
by region (western and northern health regions), age
group, sex and probability of selection in the household
The chronic disease continuum Figure 1
The chronic disease continuum.
Prevention / Delay / Early 
Detection / Care Delay / Early Detection Prevention
Death
Diagnosed
with
comorbidity
Diagnosed
without
comorbidity
Previously
undiagnosed
At
risk*
Not at 
risk
Improved health status / Deteriorating health status
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to the Australian Bureau of Statistics 1999 Estimated Res-
ident Population [17] and the 2001 Census data [18].
Exclusion criteria were applied by recruiting staff at the
initial telephone contact. Interviewers were responsible
for determining if the selected respondent had sufficient
intellectual ability to understand the implications and
requirements of participating and if not, to thank the
respondent for their time and terminate the interview.
Those people who indicated that they were too ill to par-
ticipate were similarly questioned by the interviewer to
ascertain if they had sufficient physical abilities to attend
the clinic, either using their own transport means or a taxi
provided by the study. Both categories were coded by
interviewers as "too sick" to participate in the study (n =
77). Of those who were eligible to the study and could be
contacted, 2148 respondents (26.9%) refused any partici-
pation in the study (see Figure 2) due to a number of fac-
tors including being too busy, not wanting to participate,
or considering themselves to be too old.
This cohort study did not recruit people residing in insti-
tutions, such as nursing homes, the majority of whom are
elderly women, because of the inability to randomly select
one individual from the group living arrangement. How-
ever people who had their own telephone number and
who were living in individual units attached to a nursing
home were eligible to participate. The study did not
include those people from a non-English speaking back-
ground who could not communicate sufficiently well
with the telephone interviewer and who could not answer
questions at the initial recruitment stage, although every
effort was made to encourage family members to assist in
translating. A short trial of having an interpreter present if
required for the clinic examination, was found to be nei-
ther time nor cost-effective. A review of non-participants
Table 1: Comprehensive list of variables generated from data collection
Category Variable Measurement instrument
Demographics Sex, age, contact details, occupation (kind of work done for most of life), 
number of adults (aged 18 years and over) and children in the household, 
reason for refusal (if applicable)
Recruitment (CATI) interview
Age, country of birth, year of arrival in Australia (if applicable), gross annual 
household income, age when left school, highest educational qualification 
attained, marital status, work status, Aboriginal and/or Torres Strait Islander 
status, pension/benefit status
Self-administered questionnaire
Health conditions Doctor-confirmed chronic disease status – diabetes, asthma, bronchitis, 
emphysema, heart attack, stroke, angina; anxiety, depression, a stress-
related problem or any other mental health problem
Recruitment (CATI) interview
Diabetes – doctor-confirmed prevalence, gestational diabetes, type of 
diabetes, time when first diagnosed (Phase 1B only)
Self-administered questionnaire
Asthma, bronchitis, emphysema- doctor-confirmed prevalence; perceived 
severity of asthma, time when first diagnosed (Phase 1B only)
Unhealthy behaviours Smoking (type not specified) Recruitment (CATI) interview
Doctor-confirmed high cholesterol and high blood pressure, height and 
weight (Phase 1B only)
General health and well-being (SF-36), smoking (cigarette, cigar and/or pipe 
– current habit, number of cigarettes usually – now or ever – smoked in a 
day, age when last smoked (if relevant), and age when smoking first started 
(Phase 1B only), alcohol usage (frequency and number of standard drinks), 
physical activity (number of times within last two weeks, average time per 
exercise session and intensity – walking, moderate or vigorous)
Self-administered questionnaire
Family history and medical history Family history of diabetes, heart disease and stroke; medical history of 
chronic health conditions – diabetes, asthma (including lung function), 
bronchitis, emphysema
Self-administered questionnaire
Health service utilisation Number of all health (medical and surgical) services used during last 12 
months (including general practitioner, hospital, allied health and alternative 
health)
Self-administered questionnaire
Consent to link to Medicare and pharmaceutical information Clinic examination
Biomedical measurements Blood pressure, height, weight, waist and hip circumference Clinic examination
Blood tests (fasting) Triglycerides, total cholesterol, HDL and LDL cholesterol, glucose and 
HbA1c
Clinic examination
Skin allergy measurements Saline (negative control), cockroach, house dust mite, cat dander, alternaria 
(mould), feather, rye grass, histamine [5%] (positive control)
Clinic examination
Lung function measurements Pre and post FEV1, FVC, PEF (peak expiratory flow) and predicted 
percentages
Clinic examinationEpidemiologic Perspectives & Innovations 2006, 3:4 http://www.epi-perspectives.com/content/3/1/4
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found that only four people had refused to participate in
the study due to the perceived language barrier. In addi-
tion, the small number of Aboriginal and/or Torres Strait
Islander people (n = 20) recruited in this cohort means
that no association or causality inferences can be made on
their data because of the potential for misrepresentation,
as highlighted by the Aboriginal Health Research Ethics
Committee (South Australia).
To maximise the response rate, the telephone interview
was restricted to approximately 15 minutes and a letter
and information brochure, including endorsements by
prominent South Australian sports people, were sent to
the household of each selected telephone number,
informing the household of the purpose of the study and
indicating that they would be contacted by telephone
about participating. Within two weeks of the letter and
brochure mail-out, telephone calls were made to house-
holders at various times of the day and evening, both dur-
ing the week and on the weekend. The interviews were
conducted in English by professional interviewers. Up to
ten calls were made to each household in an effort to
speak to someone. Repeated unsuccessful attempts that
resulted in either no answer, the busy signal or a message
being left on an answering machine were considered to be
"non-contacts" and regarded in the same light as refusals
(see Figure 2). Contact details supplied in the approach
letter and brochure did however enable those participants
who had not been contacted and who did want to take
part to call the study co-ordinator to arrange a mutually
convenient time for the telephone recruitment interview.
The study was pilot tested in November 1999 (n = 100)
and recruitment was conducted between December 1999
and July 2003. During planning, the importance of ensur-
ing a good response rate for the clinic visit resulted in var-
ious recruitment strategies being piloted to determine if
remuneration or blood collection method influenced the
response rate. Research from 1998 [19] suggested that a
prepaid token monetary incentive, rather than a promised
monetary or non-monetary 'reward', could have a positive
effect on the response rate – although one study cited in
this paper found that for "households not living in pov-
erty, the $20 incentive payment increased the odds by a
factor of just 1.1." (p24). This perceived benefit must be
balanced against the increased costs of providing an
incentive, particularly if it is applied to all eligible partici-
pants and not only those who ultimately take part. A sub-
sequent pilot study of 58 people from the northern and
western regions of Adelaide found that there was no sta-
tistical difference in response rates between those groups
offered a financial incentive ($20) to attend the clinic (n
= 29), and those groups who were not (n = 29); indeed,
more people agreed to participate from the latter group
(19 compared to 17). In addition, there was no difference
found in response rates between those participants who
had their blood sample taken at the clinic and those who
attended the IMVS (a medical pathology service with a
number of metropolitan and regional laboratories). It was
therefore decided that no remuneration would be offered
to study participants and that blood samples would be
taken at both TQEH and LMHS sites.
Three qualitative sub-studies using focus groups were con-
ducted during the first twelve months of the study on
community responses to the notion of participating, as
well as the notion of having participated and being
unwilling to participate. While those who were unwilling
to participate (n = 6) said they believed the study to be
worthwhile, five said their primary reason for refusal was
due to time constraints, and one did not believe in con-
ventional medicine. Other contributing factors included a
personal trauma about hospitals, doctors and needles,
and a reluctance to deal with people generally. Neither the
offer of transport to and from the clinic appointment nor
a monetary incentive influenced their decision to partici-
pate.
A unique identification number (ID) was allocated to
each household in the sample prior to the commence-
ment of recruitment, and became the identifier for the
participant. Initially this began with the number 1
through to 6,194, and did not differentiate between the
western and northern regions, however the second and
subsequent samples allocated 7,000 to 9,999 to the west-
ern regions and 10,000 to 11,999 to the northern regions
which assisted the study team to immediately recognise
which health service would be used. This ID number was
used as much as possible to replace identifying details
such as name and address on much of the participant's
Response rates Figure 2
Response rates.
Initial sample
n=10096
Eligible sample
n=8213
Interviewed
n=5850
Attended clinic
n=4060
Non-contact
n=215
2.6%
Ineligible
n=1883
18.7%
Refused interview
n=2148
26.2%
Refused clinic
n=1790
30.6%
• Non-connected numbers
• Non-residential numbers
• Fax/modem connections
• Attended clinic / Interviewed
= 69.4% participation rate
• Attended clinic / Eligible sample
= 49.4% response rateEpidemiologic Perspectives & Innovations 2006, 3:4 http://www.epi-perspectives.com/content/3/1/4
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information, to protect confidentiality and ensure ano-
nymity with stored data.
The Questionnaire Programming Language (QPL) system
was used to conduct the recruitment interviews [20]. This
is a "freeware" package that provides an efficient and reli-
able process of automating survey data by allowing imme-
diate entry of data from the interviewer's questionnaire
screen to the computer database. Its main advantage is
that it correctly sequences questions as specific answers
are given, allowing skips to another section or prompts to
be incorporated. In addition, it enforces a range of checks
on each response with most questions having a set of pre-
determined response categories. The QPL program also
allows open-ended responses to be transcribed verbatim
by the interviewer.
The same three recruiting staff were used for the telephone
interviews, to establish and maintain a rapport with eligi-
ble participants, particularly if return telephone calls to
rebook cancelled appointments were needed. These staff
developed an in-depth knowledge of the study, having
participated in the clinic examination prior to the study
starting, and were able to build upon this knowledge
through regular meetings with the study management
team.
During the recruitment interview, respondents were asked
a number of health-related questions including doctor-
confirmed chronic medical (diabetes, asthma, bronchitis,
emphysema, heart attack, stroke and angina) and mental
health disease status, and smoking. Additionally in Phase
1B, participants were asked about being told by a doctor
or nurse that they have high cholesterol and/or high
blood pressure, and if they still have either of these condi-
tions (Table 1 and Appendix B). They were further asked
for their height and weight to enable comparison with the
actual measurement recorded at the clinic, for a nested
sub-study that examined the accuracy of self-reported ver-
sus measured height and weight. Reasons for non-partici-
pation were also asked of those who refused. Information
was collected on the number of adults and children (aged
less than 18 years of age) living in the household, to deter-
mine the correct figures for later weighting of the sample
to correct selection bias. The respondent's age was
requested, rather than their date of birth, due to the sensi-
tive nature of this information and the reluctance of many
people to divulge this information over the telephone.
Information regarding the respondent's sex was collected
for verification with their name (particularly with androg-
ynous given names), and the kind of work they had
undertaken for most of their life was collected for the pur-
poses of social epidemiological analyses.
Respondents were invited to make an appointment for a
biomedical examination at TQEH (western region) or the
LMHS (northern region). Participants were sent an infor-
mation folder containing a letter confirming the appoint-
ment date and time, a questionnaire to complete and
bring to the clinic, an information sheet, a map of the
clinic, a study fridge magnet, a form for advising change
of details, information about child care facilities, and
reminders including the need to fast for eight hours before
their appointment. Study management staff also prepared
a wallet for each participant for use in the clinic, with pre-
prepared consent forms and a clinic running sheet. This
wallet was labelled with the participant's ID number,
labelled with a coloured sticker if the participant attended
the LMHS (to enable easy sorting and filing) and is used
for storage of relevant study information.
Self-reported questionnaire
The self-reported questionnaire contained questions on
demographic and health-related issues (Table 1 and
Appendix B). Many of the questions and categories used
in this questionnaire were taken from the South Austral-
ian HOS questionnaires, to enable comparisons to be
made with prevalence of selected chronic conditions and
health related risk factors in the overall South Australian
population. Previously diagnosed diabetes status and
type, asthma status and severity, and status of COPD were
determined. The questionnaire also included the Chronic
Lung Disease Index [21].
Questions also included a number of health-related risk
factor behaviours (see questionnaire, Appendix B). To
ascertain their personal alcohol risk, respondents were
asked the number of standard drinks they usually have on
a weekly and daily basis. Participants were asked if they
had ever regularly or currently smoked: if so, how many
cigarettes had been or were usually smoked a day, or if
they only smoked cigars or pipes; and at the ages at which
they first started smoking and if appropriate, when they
last gave up smoking. Physical activity was based on ques-
tions regarding the number of times in the last two weeks
and total amount of time spent walking for exercise, and
performing moderate and vigorous exercise.
Quality of life was assessed using the Short Form 36 (SF-
36), a generic instrument validated for use in Australia
[22]. The General Health Questionnaire 28 (GHQ-28)
was asked of a sub-sample (n = 1240) of participants [23]
but dropped after feedback was received that it was too
onerous for respondents to complete in addition to the
SF-36. Utilisation of health care services such as general
practitioner, community health centre, day surgery, spe-
cialist and allied health professionals was ascertained, and
demographic questions were included as listed in Table 1.Epidemiologic Perspectives & Innovations 2006, 3:4 http://www.epi-perspectives.com/content/3/1/4
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Biomedical examination
Consent and administrative information
Clinic appointments of approximately one-hour duration
were held from Monday to Saturday (to allow for people
who work full time to attend). At each appointment, the
participant was given additional detailed information
about the study and asked to sign consent forms for par-
ticipation in the study. The information given highlighted
the longitudinal nature of the study, and participants were
informed that they may be invited to participate in health-
related sub-studies. These included qualitative work that
focused on participants' experiences of living with and
managing chronic conditions [8], as well as exploring
goals and projects to maintain the sustainability of the
health and well-being of the communities involved.
Participants were also asked for secondary contact details
that would allow study staff to follow-up their wherea-
bouts if they changed address and/or telephone details,
and for details of their general practitioners for notifica-
tion of their results. A result letter detailing a number of
the clinic measurements was provided to the participant
as feedback on their health, serving as a tangible benefit
for participating.
Most Australians have been issued with either an individ-
ual or family Medicare number, which is used at each
medical or hospital occasion of service. Participants were
asked to provide consent for release of their retrospective
and prospective medical and hospital-related information
via Medicare over an eight year period, for health eco-
nomic-related and pharmaceutical use analyses. Medicare
is Australia's universal system for financing services pro-
vided by private doctors, public hospitals and some addi-
tional health costs, and is administered by the Federal
Government. Medicare collects national data on medical
provider service claims for payment purposes through the
Medicare Benefit Schedule, and therefore captures the
majority of significant occasions of health service use. It
has been shown to be more accurate than self-reported
service utilization data [24,25]. Medicare also collects
national data on medications prescribed through the
Pharmaceutical Benefits Scheme. Results of analyses of
health service and pharmaceutical use of study partici-
pants will be reported independently.
Biomedical measurements
Biomedical measurements began with blood pressure
readings, using a standard, calibrated blood pressure
sphygmomanometer. Two blood pressure measurements
were taken five to ten minutes apart while the participant
was relaxed and seated. The average of these two recorded
measures were used. Height without shoes was measured
to the nearest 0.5 centimetres using a wall-mounted stadi-
ometer (height measurement), and weight to the nearest
0.1 kilogram in light clothing and without shoes using
standard digital scales. Waist circumference was measured
to the nearest 0.1 centimetre using an inelastic tape main-
tained in a horizontal plane, with the subject standing
comfortably with weight distributed evenly on both feet.
The measurement was taken at the level of the narrowest
part of the waist. Hip circumference was also measured
using an inelastic tape, at the level of the maximum pos-
terior extension of the buttocks. Three measurements of
the waist and hip were taken and the mean for each was
calculated.
A fasting blood sample of approximately 10 ml was taken
to measure triglyceride, total cholesterol, high density
lipoprotein (HDL), low density lipoprotein (LDL), glu-
cose and glycosylated haemoglobin (HbA1c) levels.
Skin allergy tests were conducted in relation to asthma to
determine reactions to the following allergens: saline
(negative control), histamine 5% (positive control), rye
grass, cat dander, house dust mite, alternaria (mould),
feather and cockroach. The test involved pricking the fore-
arm skin with a lancet via a drop of allergen. The diameter
of the skin wheal was measured (in millimetres) both ver-
tically and horizontally at 15 minutes, and the two meas-
urements were averaged.
Lung function tests were performed using a Microlab
2000 spirometer both pre- and post-salbutomol adminis-
tration [26]. The tests involved participants being asked to
sit upright, put their feet firmly on the floor, and have a
nose clip applied. They were then asked to take a deep
breath through their mouth to total lung capacity, to seal
their lips around the mouthpiece of the spirometer and
then to forcefully expel the breath through the mouth-
piece as fast and as hard as they could to residual volume.
Once two acceptable spirograms had been registered, par-
ticipants were administered 400 µg of salbutomol via a
metered dose inhaler (MDI) and a spacer. Another two
acceptable spirograms were performed ten minutes after
the salbutomol.
A summary of the data collected from participants in the
recruitment interview, self-completed questionnaire, and
the biomedical examination is listed in Table 1, with the
data collection forms in the appendices. The study team
cast a wide net to gather baseline information across a
range of health outcomes, risk factors and determinants.
For quality control purposes, following the completion of
Phase 1A, a telephone interview of a random selection of
340 participants for an exit study was conducted to
explore the experiences, perceptions and satisfaction
regarding the recruitment process, information folder and
clinic examination. All provided valuable feedback forEpidemiologic Perspectives & Innovations 2006, 3:4 http://www.epi-perspectives.com/content/3/1/4
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conducting the remainder of the study, and suggestions
(such as needing more space in the clinic) lead to
improvements in clinic accommodation.
Establishing and maintaining a relationship with the study 
cohort
Several strategies to encourage participation and maintain
contact with participants over the long-term were
employed, based on previous successful longitudinal
studies such as the Framingham Heart Study, the Bussel-
ton (Western Australia) Study and the Women's Health
(Australia) Study.
The use of an easily recognizable study logo (designed in-
house and incorporating the State's floral emblem, Sturt's
Desert Pea) on all items associated with the study includ-
ing brochures, forms, correspondence, reports, conference
presentations and posters, and a fridge magnet promoted
the study's identity among the study team, participants,
and the wider health and research community.
In the initial approach, potential participants were invited
to assist both themselves and their community to improve
their health, as well as contribute to important health
knowledge that would help their region lead the way in
community health care in Australia. A second round of
brochures included with the approach letter sent to partic-
ipants recruited towards the middle and end of the study,
included favourable comments made by existing partici-
pants during an exit study. This theme was repeated in the
December 2003 newsletter with the use of quotations
from participants in the Framingham Heart Study, com-
menting how they not only valued the regular free health
check, but also the altruistic benefits of the study. These
sentiments and the importance of their ongoing participa-
tion (especially in light of the inability to substitute other
people if they withdrew) are echoed by recruitment, study
research and front-line clinic staff in all verbal and written
communications with participants. Participants were fur-
ther reassured in study materials of the confidentiality of
their personal and medical information given, and its de-
identification prior to being used for research purposes, as
well as their ability to withdraw from the study without
change to their health care from the services involved.
In addition to annual newsletters and notification of their
individual clinic results, participants are also sent birthday
cards as a means of maintaining contact and providing
them with an opportunity to inform the study team of any
changes in their contact details. Participants have reported
favourable comments and expressions of appreciation
about these communications to study team and clinic
staff during routine clinic visits and follow-up telephone
calls. As another means of maintaining contact with the
cohort, a telephone questionnaire was conducted with
Phase 1A participants (response rate 91.7%) in April
2002, which also served to provide information about
whether participants followed up clinic results with gen-
eral practitioners, and if there were any changes in per-
sonal circumstances, as well as a number of questions
relating to asthma and diabetes. Two local functions were
also held for study participants, the study team, and local
and State government dignitaries, to launch the key bio-
medical findings from Phase 1A.
While mail and telephone remain the major forms of
communication with participants, the study team has rec-
ognised the growing trend towards use of home comput-
ers and the World Wide Web, with approximately one
quarter of the Australian population (over 5 million peo-
ple) reporting use of the internet including over 30% of
people aged 55 years and over [27]. Therefore, to assist
with dissemination to study participants, and also the
wider Australian community and health professionals
worldwide, a dedicated website http://www.nwadelaide
healthstudy.org was developed, highlighting aspects of
the study including the study team, results, and frequently
asked questions. The website also provides links to all
study reports, and conference presentations and posters,
as well as an online enquiry form that generates an email
to the study team, for questions or notification of change
of contact details.
Tracking of participants has included the use of the White
Pages telephone directory, the following up of secondary
contacts and the State Electoral Roll. The database of all
deaths registered in South Australia through the Births,
Deaths and Marriages Registration Office has been used to
search for possible matches with the study cohort, and
plans are being made to access the National Death Index
for possible deaths of study participants now living inter-
state.
Lessons learnt so far
Lessons learnt from Stage 1 of the study and technological
developments since then, resulted in the following
improvements being implemented for Stage 2 of the study
(undertaken from May 2004 to February 2006):
• The use of hand held computers (hp iPAQ Pocket PC
h4000 series) rather than paper-based forms for data entry
of clinic measurements: this allows for immediate clean-
ing and analysis at the completion of the study, as well as
baseline measurements to be fed back to participants at
the clinic visit. These computers are also used by clinic
staff to enter subsequent biomedical results from the
blood and lung function tests as back-up tasks when par-
ticipants do not attend their appointment. The initial
financial outlay more than justified the ease of use by
clinic staff, the immediacy of data transfer for researchEpidemiologic Perspectives & Innovations 2006, 3:4 http://www.epi-perspectives.com/content/3/1/4
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staff as well as result letters to participants and their doc-
tors, and the improved storage and confidentiality of data.
• Use of home and nursing home visits for participants
whose health has deteriorated since Stage 1.
• The collection of information about all medications
being taken (including vitamins, patches and contracep-
tives): this will provide information about contraindica-
tions and possible effects on diagnosed and undiagnosed
conditions and risk factors.
• The collection of both self-reported and biomedical
measurement of some subjects (eg height and weight):
this will be used to verify self-reporting behaviour such as
the tendency to over-report height and under-report
weight, as well as identify population groups who may
believe their condition is being sufficiently well-managed,
but whose biomedical results belie this.
• The storage of a blood sample from each participant for
further testing: tests are yet to be determined but may
include the measurement of Vitamin D and parathyroid
hormones which are linked to osteoporosis, and c-reactive
protein in relation to arthritis and coronary heart disease.
Future plans for the cohort
Future biomedical measurement of the cohort is planned
every three years, with an interim follow-up telephone
questionnaire scheduled for 2007 to maintain contact
with participants and for data collection purposes. Stage 3
(which is scheduled to occur in 2008–09) would benefit
from the further use of technology to scan self-report
questionnaires and the possible use of automatic SMS tex-
ting to mobile telephones for clinic visit reminders. Over
one-third of our participants have provided their mobile
telephone numbers, and email addresses are also being
collected in recognition of these modern and frequently-
used forms of communication.
Additional chronic conditions as yet to be investigated
include sleep apnoea and incontinence. Nutrition is
another health-related risk factor for which data could be
collected in future stages. The collection of consent for
linkage with state-based hospital databases, as well as
additional information regarding the participant's past
history for life-course analysis, are being considered as
future data collection items. In hindsight, information
regarding the age of death from heart disease (if <50 years
of age) of first generation family members would have
provided valuable information regarding the risk of devel-
oping heart diseases. Valuable lessons can be learnt from
the Framingham Heart Study for their specialist targeted
recruitment of ethnic populations to address the minori-
ties within the community, and in their recruitment of
participants' spouses and children for genetic/family links
regarding chronic disease. Genetic testing of NWAHS par-
ticipants may be considered in the future.
Description of cohort
Table 4 provides the demographic profile of the study par-
ticipants (n = 4060), including highest level of education
achieved, annual gross household income, marital and
work status.
Definitions of chronic conditions and health-related risk 
factors
Definitions and cut-off points for the chronic conditions
and related risk factors were drawn from a range of
accepted local, national and international evidence-based
guidelines and standards. Subsequent analyses for report
writing, presentations and publications are adapted to suit
the targeted audience. The following definitions and cut-
off points were used in this paper for the purposes of clas-
sifying study participants along the chronic disease con-
tinuum.
Alcohol risk was then calculated based on the 1989
National Heart Foundation Risk Factor Prevalence study
classification formulae [28]. This criterion was selected to
enable comparisons with past HOS questionnaires.
Respondents were categorised as non-drinkers, no risk
drinkers, low risk drinkers, intermediate risk drinkers,
high risk drinkers and very high risk drinkers (Table 2,
Table 3). These categories were further collapsed into non
Table 2: Alcohol risk: categories of risk level [26]
Frequency of drinking Number of drinks
1–2 3–4 5–8 9–12 13–20 >20
Less than once a week B B B C D E
1 or 2 days B B B C D E
3 or 4 days B B C D E F
5 or 6 days B C D E F F
Every day B C D E F FEpidemiologic Perspectives & Innovations 2006, 3:4 http://www.epi-perspectives.com/content/3/1/4
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drinkers or no risk drinkers; low risk; and intermediate to
very high risk for analysis.
Participants were classified as non-smokers, ex-smokers or
current smokers based on their responses to questions
about current and past regular habits of smoking ciga-
rettes, cigars or pipes. Their level of smoking (non-
smoker, ex-smoker, light, moderate and heavy) was deter-
mined by the number of cigarettes smoked per day; if they
indicated that they smoked only cigars or pipes, they were
considered to be light smokers. These questions were also
included to enable comparison with past HOS question-
naires, used to monitor the state's smoking prevalence by
The Cancer Council South Australia.
The physical activity questions from the Australian
National Health Surveys (conducted in 1989/90, 1995
and 2001) were used in this study to also enable compar-
ison with national data – the now recommended Active
Australia questions had not been formulated when the
study was initiated. Physical activity level was based on a
score derived from the formula "e × t × i"" where e was
number of times walking, moderate and/or vigorous exer-
cise was undertaken during the past two weeks, t was the
average amount of time spent on each exercise session and
i was the intensity (walking scored at 3.5, moderate exer-
cise scored at 5.0 or vigorous exercise scored at 7.5). Par-
ticipants were classified thus: sedentary (score less than
100, including no exercise), low (score of at least 100 but
less than 1600), moderate (score of at least 1600 to 3200,
or more than 3200 but less than 2 hours of vigorous exer-
cise) and high (score of at least 3200 and 2 hours or more
of vigorous exercise) [29].
High blood pressure was defined as systolic blood pres-
sure greater than or equal to 140 mmHg and/or diastolic
blood pressure greater or equal to 90 mmHg [28,30].
Body mass index (BMI) was calculated as weight (in kilo-
grams) divided by height(in metres)2. Overweight was
defined as BMI ≥ 25.0 and obesity as BMI ≥ 30.0 [31]. A
waist circumference (WC) of ≥ 95 cm for males or ≥ 80 cm
for females was defined as the level at which no further
weight should be gained. A WC of ≥ 100 cm for males and
≥ 90 cm for females was defined as the level at which
weight reduction should be recommended [32,33]. A
high waist-hip ratio was defined as > 1.0 for males and >
0.85 for females [34].
High cholesterol was defined as total cholesterol greater
than or equal to 5.5 mmol/L [35]. Impaired fasting glu-
cose (IFG) was defined as fasting plasma glucose (FPG) of
at least 6.1 mmol/L and less than 7.0 mmol/L [36]. Partic-
ipants were considered to have undiagnosed diabetes if
their FPG was greater than or equal to 7.0 mmol/L and
they did not report being told by a doctor that they had
diabetes.
A skin allergy test was considered to be successful if the
participant's histamine (positive control) wheal was
greater than 2 mm in diameter. Participants were defined
as having an allergic reaction to the selected allergen if the
skin wheal was greater than the negative control by 2 mm
or more in diameter.
Participants were considered to have asthma if they expe-
rienced at least a 15% increase in their forced expiratory
volume in one second (FEV1) from pre-Ventolin to post-
Ventolin; if they had at least a 12% increase in FEV1 from
pre-Ventolin to post-Ventolin and their absolute differ-
ence in FEV1 was greater than 200 ml; or if they reported
being told by a doctor that they had asthma and that it
was current.
Participants were considered to have COPD if their meas-
ured FEV1:FVC (forced vital capacity) ratio was less than
the result of the formula (87.21 - (0.18 × age) × 0.882) for
males, and (89.10 - (0.19 × age) × 0.893) for females
[37,38]. In this formula, 0.882 and 0.893 represent one
minus two standard deviations from the predicted mean
for males and females, respectively. People with previ-
ously undiagnosed COPD were defined as having COPD
according to the above European Respiratory Society crite-
ria, but who did not report having been told by a doctor
that they had COPD (chronic bronchitis or emphysema).
Data analysis
Data were weighted to the 1999 Estimated Resident Pop-
ulation and 2001 Census [17,18], the Australian Bureau
Table 3: Alcohol risk levels [26]
Category Description Risk
Men Women
A Non-drinkers None None
B Average daily intake of less than 3 drinks None Low
C Average daily intake of 4 drinks or 9–12 drinks in any day Low Intermediate
D Average daily intake of 5–8 drinks or occasional excess Intermediate High
E Average daily intake of 9–12 drinks or frequent or great occasional excessive intake High Very high
F Average daily intake of over 12 drinks Very high Very highEpidemiologic Perspectives & Innovations 2006, 3:4 http://www.epi-perspectives.com/content/3/1/4
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of Statistics official measures of the Australian resident
population, by age group, sex, region and probability of
selection in the household, to ensure that the sample was
representative of the population in the northern and west-
ern regions of Adelaide. The data were analysed using
SPSS (Version 10.0) [38].
Segmentation of the cohort for selected chronic conditions
Table 5 provides an initial segmentation of the cohort's
baseline chronic condition status along a continuum (Fig-
ure 1). Participants were defined as "not at risk" (Figure 1)
if they did not have any of the chronic conditions: that is,
they did not have asthma, COPD or diabetes, nor a self-
reported doctor diagnosis of heart attack, stroke or angina,
nor did they have any risk factors (obesity, high waist/hip
ratio, current smoker, high blood pressure, high total cho-
lesterol, a sedentary physical activity level, intermediate to
very high alcohol risk, gestational diabetes, or skin aller-
gies). Those in the category "at risk" (see Introduction,
paragraph 2) were considered to have either IFG, and/or
one or more of the above risk factors. Participants allo-
cated to the category "previously undiagnosed" were con-
sidered to have no self-reported doctor diagnosis of
asthma, COPD or diabetes but one or more of these con-
ditions detected at the clinic. Participants "diagnosed with
or without comorbidity" were considered to have a self-
reported doctor diagnosis of asthma, COPD or diabetes
and/or a self-reported doctor diagnosis of either heart
attack, stroke or angina.
The distribution of participants in the chronic disease
continuum shows that almost one in five people (18.8%)
had a self-reported doctor diagnosis of either diabetes,
asthma, COPD, heart attack, stroke and/or angina. Over-
all, 5.8% had no risk factors for chronic disease. Almost
three out of four people (71.5%) did not have any of the
chronic conditions of interest (undiagnosed or diag-
nosed) but had at least one risk factor that may lead to one
or more of these conditions developing.
Conclusion
The NWAHS has provided valuable baseline evidence
through its use of a continuum for selected chronic dis-
eases. South Australia has an ageing population and the
highest elderly population of all the states and territories
in Australia, with 13.8% aged 65 years and over [39].
These facts are important given the association of age with
many chronic conditions, health service use and costs.
This cohort study provides a unique opportunity to pro-
vide much needed measured and self-reported informa-
tion to fill identified gaps in the study of chronic diseases
and risk factors. Its sound epidemiological base, large ran-
dom sample and reasonable response rate allow its gener-
alisability, firstly for the local community it represents,
secondly for South Australians and thirdly, for the wider
Australian population, whilst providing useful research
results for the international public health community.
The longitudinal dimension of the study has been realised
with participants having returned to the clinic for their fol-
low-up visit in 2004–06. This will ensure provision of rich
and varied data that should contribute to the overall
Table 4: Profile of participants
Variable n %
Sex
Male 1988 49.0
Female 2072 51.0
Age group (years)
18 – 34 1411 34.8
35 – 54 1437 35.4
55 – 74 878 21.6
75 + 335 8.2
Area of residence
Western suburbs 1853 45.6
Northern suburbs 2207 54.4
Highest education level obtained
Secondary 1751 43.1
Trade/Apprenticeship/Certificate/Diploma 1641 40.4
Bachelor degree or higher 475 11.7
Not stated 193 4.8
Gross household income
Up to $20,000 902 22.2
$20,001–40,000 1008 24.8
$40,001–60,000 899 22.2
More than $60,000 992 24.4
Not stated 258 6.4
Aboriginal or Torres Strait Islander origin
Yes 20 0.5
No 3548 87.4
Not stated 492 12.1
Country of birth
Australia 2865 70.6
UK or Ireland 645 15.9
Europe, Asia & Other 524 12.9
Not stated 25 0.6
Marital status
Married or living with partner 2525 62.2
Separated/Divorced 331 8.1
Widowed 232 5.7
Never married 940 23.1
Not stated 32 0.8
Work status
Full time employed 1537 37.9
Part time/Casual employed 728 17.9
Unemployed 173 4.3
Home duties/Retired 1239 30.5
Student/Other 333 8.2
Not stated 49 1.2
Receive pension from Department of Social Security
Yes 1286 31.7
No 2698 66.5
Don't know/Not stated 75 1.8
Total 4060 100.0Epidemiologic Perspectives & Innovations 2006, 3:4 http://www.epi-perspectives.com/content/3/1/4
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improvement of health and well-being among present
and future generations, and will be the subject of a future
paper.
In addition to the baseline prevalence data that the
NWAHS has provided, the longitudinal nature of the
study will, in time, enable the natural history of condi-
tions to be examined. The characteristics of people who
moved to the right along the disease continuum to worse
states of health over time will be compared to those who
do not move. Valuable lessons for health promotion may
be learned from those participants who moved left along
the continuum, to an improved state of health. Viewing
health and disease as a continuum in this study means
that recommendations for health interventions, planning
and policy will be focused on prevention and early inter-
vention of risk factors and disease, rather than just man-
agement and delay of chronic conditions.
Both Stage 1 and 2 of the study have been funded by aca-
demic and government research grants, reducing certain
conflicts of interest that might result from sponsorship by
large corporations, such as pharmaceutical companies.
The NWAHS is in a unique position to provide valuable
baseline biomedical and self-reported data on a range of
health conditions and their related risk factors, pertaining
to both men and women aged 18 years and over, and
promises to deliver follow-up evidence-based informa-
tion that will grow in value as each examination is under-
taken.
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Table 5: Segmentation of study cohort for selected chronic diseases – asthma, COPD and diabetes
n % (95% CI)
Not at risk of chronic disease 234 5.8 (5.1 – 6.6)
At risk of chronic disease 2871 71.5 (70.1 – 72.9)
Undiagnosed chronic disease 156 3.9 (3.3 – 4.5)
Diagnosed chronic disease 755 18.8 (17.6 – 20.0)
Total 4015* 100.0
*45 cases excluded due to missing responses in questionnaire or insufficient FEV1 or FVC results
# See Introduction, paragraph 2
NB: Chronic diseases – asthma, COPD, diabetes. Details of categories are to be found in "Classification of continuum". Where overlap occurred 
between categories, participant included in more serious category, ie person with undiagnosed asthma and self-reported diabetes considered to be 
in "Diagnosed chronic disease" category.Epidemiologic Perspectives & Innovations 2006, 3:4 http://www.epi-perspectives.com/content/3/1/4
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Appendix A
The following persons comprised the study team for Stage
1 of the North West Adelaide Health Study 2000–2003:
Principal/Chief Investigators: R Ruffin, A Taylor, D Wil-
son, J Cheek, P Phillips, R Adams, K Price Co-Investiga-
tors/Collaborators: N Potts, P Zalewski, W Jeffries, C Beng
Research/Study Management: E Dal Grande, C Chittlebor-
ough, J Grant, T Gill, S Appleton, C Oster, K Baldock, B
Hurst, L Caudle, M Burke, J Hickling, J Paynter
Clinic Co-ordination: I Meagher, S Pickering
Clinic: E Jansen, M Taylor, R Battersby, N Labiszewski, A
Scardigno J Brown, A O'Grady, J Middleton, A Brindley, L
Kovalenko, J Barnett
Recruitment:J Dibble, K Smith, B Webb, S Ogilvy, L Parry,
D Hart.
Appendix B
PDF documents: Telephone recruitment questionnaire,
Self-report questionnaire, Clinic running sheet
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